Literature DB >> 15172735

Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.

Rudy J Castellani1, Mark A Smith, George Perry, Robert P Friedland.   

Abstract

Amyloid deposition within cerebral vessels, or cerebral amyloid angiopathy (CAA), is common in advanced age and even more common in Alzheimer's disease. CAA may be complicated by lobar intracerebral hemorrhage, while rare kindreds of autosomal dominant CAA also show propensity for intracerebral hemorrhage, due to germline mutations in specific amyloidogenic precursor proteins and apparent compromise of structural integrity of the blood vessel wall due to marked amyloid deposition. The relationship between cerebral amyloid angiopathy and cognitive dysfunction, however, is less clear. While cognitive dysfunction in familial CAA is likely related to prodigious amyloid deposits and vascular luminal compromise (e.g., hereditary cerebral hemorrhage with angiopathy-Dutch type (HCHWA-D)), cerebral amyloid angiopathy with intracerebral hemorrhage often presents sporadically in cognitively intact elderly patients. Moreover, while about 80% of subjects with Alzheimer's disease have demonstrable amyloid beta within blood vessel walls at autopsy, the vast majority of these fail to suffer clinically relevant intracerebral hemorrhage during life. The remaining 20% manage to progress and die of their disease with virtual no amyloid within blood vessels. Thus, the role of amyloid beta deposits in cerebral vessels as regards cognitive function on the one hand, and tendency for hemorrhage on the other, remain to be resolved for sporadic late onset Alzheimer's disease and CAA. Recent studies on transgenic APP23 mice suggest a relationship between passive immunization and amyloid angiopathy-associated cerebral hemorrhage, although the mechanism of hemorrhage was unclear from the data presented. We suggest that amyloid accumulation represents a response to chronic stress, and that the neurodegenerative process occurs at the neuronal level, encompassing oxidative stress and aberrant cell cycle activation. As such, CAA represents tissue homeostasis, such that an abrupt perturbation of this balance (e.g., amyloid beta immunization) is deleterious.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172735     DOI: 10.1016/j.neurobiolaging.2003.12.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

Review 1.  Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Authors:  Margaret Flanagan; Eric B Larson; Caitlin S Latimer; Brenna Cholerton; Paul K Crane; Kathleen S Montine; Lon R White; C Dirk Keene; Thomas J Montine
Journal:  Biochim Biophys Acta       Date:  2015-08-28

2.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

Authors:  Veronica Lifshitz; Ronen Weiss; Tali Benromano; Einat Kfir; Tamar Blumenfeld-Katzir; Catherine Tempel-Brami; Yaniv Assaf; Weiming Xia; Tony Wyss-Coray; Howard L Weiner; Dan Frenkel
Journal:  Neurobiol Aging       Date:  2011-03-02       Impact factor: 4.673

Review 3.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

4.  Microvessel occlusions alter amyloid-beta plaque morphology in a mouse model of Alzheimer's disease.

Authors:  Yuying Zhang; Evan D Bander; Yurim Lee; Celia Muoser; Chris B Schaffer; Nozomi Nishimura
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-19       Impact factor: 6.200

Review 5.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

6.  Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid.

Authors:  Susan A Austin; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-07       Impact factor: 6.200

7.  Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments.

Authors:  Haizhi Wang; Nianli Sang; Can Zhang; Ramesh Raghupathi; Rudolph E Tanzi; Aleister Saunders
Journal:  Biochemistry       Date:  2015-04-28       Impact factor: 3.162

8.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

Review 9.  Is passive immunization for Alzheimer's disease 'alive and well' or 'dead and buried'?

Authors:  Gregory A Jicha
Journal:  Expert Opin Biol Ther       Date:  2009-04       Impact factor: 4.388

Review 10.  Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy.

Authors:  Michael Nehls
Journal:  J Mol Psychiatry       Date:  2016-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.